Clinical Efficacy of Empirical Therapy in Children with Vasovagal Syncope

Chunyan Tao1,2, Yaxi Cui1, Chunyu Zhang1

  • 1Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.

Insights

Empiric treatments for pediatric vasovagal syncope showed limited efficacy in reducing recurrence. Further studies are needed to explore individualized therapies for better outcomes in children.

Area of Science:

  • Pediatrics
  • Cardiology
  • Clinical Research

Background:

  • Vasovagal syncope is common in children.
  • Empiric treatment strategies are widely used but their efficacy is not well-established.
  • This study evaluated different empiric treatments for pediatric vasovagal syncope.

Purpose of the Study:

  • To assess the efficacy of four different empiric treatment strategies for vasovagal syncope in children.
  • To compare the recurrence rates of syncope and presyncope among treatment groups.
  • To determine if conventional treatment, oral rehydration salts, metoprolol, or midodrine hydrochloride yield different outcomes.

Main Methods:

  • Retrospective case-control study of 181 children diagnosed with vasovagal syncope.
  • Participants were assigned to four groups: conventional treatment, conventional + oral rehydration salts, conventional + metoprolol, or conventional + midodrine hydrochloride.
  • Kaplan-Meier curves and log-rank tests were used to analyze recurrence rates over a median follow-up of 20 months.

Main Results:

  • No significant difference in the recurrence of syncope or presyncope was observed among the four empiric treatment groups.
  • The log-rank test showed no statistically significant variation in outcomes between the treatment strategies (χ = 1.328, p = 0.723).
  • Eleven out of 181 patients were lost to follow-up.

Conclusions:

  • Current unselected empiric therapies for pediatric vasovagal syncope demonstrate limited effectiveness in preventing recurrence.
  • Individualized treatment approaches tailored to specific patient characteristics may offer better therapeutic results.
  • Further research is warranted to develop and validate personalized treatment protocols for vasovagal syncope in children.

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
138
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
151
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
70
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
1.1K